Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tbx5
|
ENSMUSG00000018263.8 | T-box 5 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr5_119866991_119867142 | Tbx5 | 30911 | 0.138762 | -0.69 | 4.9e-09 | Click! |
chr5_119857117_119857325 | Tbx5 | 21066 | 0.156569 | 0.59 | 2.1e-06 | Click! |
chr5_119832485_119832674 | Tbx5 | 89 | 0.889351 | 0.43 | 1.1e-03 | Click! |
chr5_119837024_119837175 | Tbx5 | 944 | 0.536521 | 0.42 | 1.2e-03 | Click! |
chr5_119836588_119836964 | Tbx5 | 621 | 0.700175 | 0.38 | 4.6e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_174347204_174348264 | 33.59 |
Gm20721 |
predicted gene, 20721 |
1022 |
0.44 |
chr9_109094576_109096217 | 14.04 |
Plxnb1 |
plexin B1 |
7 |
0.95 |
chr10_77221010_77221202 | 11.95 |
Pofut2 |
protein O-fucosyltransferase 2 |
38112 |
0.13 |
chr4_107366540_107366691 | 11.34 |
Ndc1 |
NDC1 transmembrane nucleoporin |
1169 |
0.38 |
chrX_123721926_123722462 | 11.26 |
Rps12-ps23 |
ribosomal protein S12, pseudogene 23 |
13617 |
0.18 |
chrX_123943434_123943951 | 11.17 |
Rps12-ps20 |
ribosomal protein S12, pseudogene 20 |
13582 |
0.23 |
chr10_127508848_127510720 | 10.85 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chrX_123271195_123271712 | 10.81 |
Rps12-ps21 |
ribosomal protein S12, pseudogene 22 |
13591 |
0.15 |
chrX_123500550_123501093 | 10.75 |
Rps12-ps22 |
ribosomal protein S12, pseudogene 22 |
13606 |
0.18 |
chr8_94354109_94354553 | 10.57 |
Slc12a3 |
solute carrier family 12, member 3 |
715 |
0.52 |
chr3_100488535_100489982 | 9.28 |
Tent5c |
terminal nucleotidyltransferase 5C |
60 |
0.85 |
chr7_4684281_4684888 | 9.24 |
Hspbp1 |
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1 |
77 |
0.93 |
chr7_140955920_140956826 | 9.10 |
Ifitm2 |
interferon induced transmembrane protein 2 |
386 |
0.43 |
chr13_40869116_40869281 | 9.02 |
Mir5124a |
microRNA 5124a |
3407 |
0.13 |
chr8_94974142_94974748 | 8.81 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
306 |
0.84 |
chr17_80468459_80468787 | 8.68 |
Sos1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
11346 |
0.21 |
chr8_36668721_36669167 | 8.62 |
Dlc1 |
deleted in liver cancer 1 |
55001 |
0.16 |
chr4_45483725_45483909 | 8.36 |
Shb |
src homology 2 domain-containing transforming protein B |
1015 |
0.5 |
chr14_32022577_32022765 | 8.23 |
Galnt15 |
polypeptide N-acetylgalactosaminyltransferase 15 |
6318 |
0.15 |
chr7_5060805_5061447 | 8.03 |
Gm45133 |
predicted gene 45133 |
923 |
0.22 |
chr10_80150235_80151164 | 8.01 |
Midn |
midnolin |
242 |
0.82 |
chr6_124919273_124920636 | 7.99 |
Ptms |
parathymosin |
149 |
0.88 |
chr2_129232031_129232345 | 7.80 |
9830144P21Rik |
RIKEN cDNA 9830144P21 gene |
1609 |
0.21 |
chr2_127371183_127371562 | 7.69 |
Adra2b |
adrenergic receptor, alpha 2b |
8086 |
0.14 |
chr4_46407004_46407329 | 7.52 |
Hemgn |
hemogen |
2930 |
0.18 |
chr11_69837611_69838644 | 7.41 |
Nlgn2 |
neuroligin 2 |
343 |
0.43 |
chr17_47909349_47909983 | 7.41 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr17_73022390_73023322 | 7.40 |
Gm30420 |
predicted gene, 30420 |
6222 |
0.24 |
chr9_119469764_119470364 | 7.38 |
Exog |
endo/exonuclease (5'-3'), endonuclease G-like |
25077 |
0.13 |
chr4_46404152_46404582 | 7.36 |
Hemgn |
hemogen |
131 |
0.94 |
chr5_77130277_77130581 | 7.35 |
Gm15831 |
predicted gene 15831 |
8081 |
0.13 |
chr14_14012273_14013624 | 7.30 |
Atxn7 |
ataxin 7 |
196 |
0.95 |
chr11_120304745_120305917 | 7.18 |
Bahcc1 |
BAH domain and coiled-coil containing 1 |
15538 |
0.09 |
chr11_109555645_109556032 | 7.16 |
Arsg |
arylsulfatase G |
12084 |
0.16 |
chr15_98608664_98610204 | 7.07 |
Adcy6 |
adenylate cyclase 6 |
598 |
0.55 |
chr16_92494535_92494840 | 7.03 |
Clic6 |
chloride intracellular channel 6 |
3447 |
0.19 |
chr2_153239383_153239670 | 6.98 |
Plagl2 |
pleiomorphic adenoma gene-like 2 |
1618 |
0.26 |
chrX_36988645_36990253 | 6.96 |
Septin6 |
septin 6 |
42 |
0.97 |
chr14_25687410_25687792 | 6.96 |
Ppif |
peptidylprolyl isomerase F (cyclophilin F) |
6553 |
0.14 |
chr2_30658442_30659224 | 6.91 |
Gm14486 |
predicted gene 14486 |
11075 |
0.15 |
chr12_17505834_17506128 | 6.88 |
Odc1 |
ornithine decarboxylase, structural 1 |
38813 |
0.11 |
chr8_122174592_122174743 | 6.83 |
Zfp469 |
zinc finger protein 469 |
83953 |
0.07 |
chr2_145233569_145233742 | 6.75 |
Slc24a3 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
8956 |
0.28 |
chr13_19921455_19921835 | 6.72 |
Gm5446 |
predicted gene 5446 |
74159 |
0.1 |
chr11_102365773_102366061 | 6.69 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
286 |
0.82 |
chr13_99355496_99355662 | 6.60 |
Mrps27 |
mitochondrial ribosomal protein S27 |
10035 |
0.19 |
chr2_166398944_166399580 | 6.59 |
Gm14268 |
predicted gene 14268 |
1075 |
0.58 |
chr14_25738589_25738953 | 6.57 |
Zcchc24 |
zinc finger, CCHC domain containing 24 |
18979 |
0.13 |
chr10_111583097_111583314 | 6.50 |
4933440J02Rik |
RIKEN cDNA 4933440J02 gene |
11068 |
0.16 |
chr4_140860203_140860394 | 6.48 |
4930515B02Rik |
RIKEN cDNA 4930515B02 gene |
12395 |
0.12 |
chr11_97424148_97424313 | 6.47 |
Arhgap23 |
Rho GTPase activating protein 23 |
8697 |
0.16 |
chr4_139335168_139335391 | 6.46 |
AL807811.1 |
aldo-keto reductase family 7 member A2 (AKR7A2) pseudogene |
1901 |
0.15 |
chr19_53329198_53330470 | 6.46 |
Mxi1 |
MAX interactor 1, dimerization protein |
26 |
0.97 |
chr3_145590718_145590904 | 6.44 |
Znhit6 |
zinc finger, HIT type 6 |
5057 |
0.23 |
chr15_73743492_73743968 | 6.44 |
Ptp4a3 |
protein tyrosine phosphatase 4a3 |
3904 |
0.2 |
chr9_36950297_36951358 | 6.40 |
Pknox2 |
Pbx/knotted 1 homeobox 2 |
36445 |
0.13 |
chr9_72985318_72986161 | 6.36 |
Ccpg1 |
cell cycle progression 1 |
120 |
0.74 |
chr19_57098269_57098861 | 6.30 |
Ablim1 |
actin-binding LIM protein 1 |
20348 |
0.24 |
chr2_168023853_168024004 | 6.28 |
Ripor3 |
RIPOR family member 3 |
13310 |
0.14 |
chr8_11476606_11477276 | 6.24 |
E230013L22Rik |
RIKEN cDNA E230013L22 gene |
988 |
0.37 |
chr15_101976894_101977736 | 6.22 |
Krt78 |
keratin 78 |
23028 |
0.09 |
chr3_147287433_147287899 | 6.16 |
Gm6074 |
predicted gene 6074 |
94748 |
0.08 |
chr6_115240559_115240742 | 6.08 |
Syn2 |
synapsin II |
1656 |
0.33 |
chr11_48873308_48874023 | 6.08 |
Irgm1 |
immunity-related GTPase family M member 1 |
1982 |
0.19 |
chr13_75733796_75734110 | 6.08 |
Gm48302 |
predicted gene, 48302 |
6674 |
0.14 |
chr17_70850487_70852089 | 6.08 |
Tgif1 |
TGFB-induced factor homeobox 1 |
81 |
0.94 |
chr11_21079484_21079662 | 6.07 |
Peli1 |
pellino 1 |
11718 |
0.2 |
chr3_103171228_103172264 | 6.06 |
Bcas2 |
breast carcinoma amplified sequence 2 |
3 |
0.97 |
chr14_75837044_75838069 | 6.02 |
Gm48931 |
predicted gene, 48931 |
3930 |
0.16 |
chr6_31614465_31614633 | 6.00 |
Gm43154 |
predicted gene 43154 |
9260 |
0.19 |
chr2_160603448_160603635 | 5.99 |
Gm14221 |
predicted gene 14221 |
16430 |
0.16 |
chr8_126805357_126806196 | 5.97 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
33457 |
0.16 |
chr2_180303470_180303946 | 5.95 |
Rbbp8nl |
RBBP8 N-terminal like |
13829 |
0.11 |
chr11_69901245_69901922 | 5.87 |
Neurl4 |
neuralized E3 ubiquitin protein ligase 4 |
233 |
0.66 |
chr2_30463478_30464399 | 5.87 |
Ier5l |
immediate early response 5-like |
10281 |
0.13 |
chr6_113691177_113691368 | 5.85 |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
527 |
0.5 |
chr12_106027461_106027735 | 5.85 |
Vrk1 |
vaccinia related kinase 1 |
1791 |
0.4 |
chr19_10203179_10203536 | 5.82 |
Fen1 |
flap structure specific endonuclease 1 |
537 |
0.44 |
chr10_127878790_127878958 | 5.82 |
Rdh7 |
retinol dehydrogenase 7 |
9456 |
0.09 |
chr10_118064868_118065238 | 5.80 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
47464 |
0.11 |
chr2_32127943_32128094 | 5.80 |
Prrc2b |
proline-rich coiled-coil 2B |
23064 |
0.1 |
chr19_24794396_24794754 | 5.73 |
Pgm5 |
phosphoglucomutase 5 |
31497 |
0.16 |
chr12_25098272_25099055 | 5.72 |
Id2 |
inhibitor of DNA binding 2 |
1523 |
0.35 |
chr15_102017591_102018334 | 5.67 |
Krt18 |
keratin 18 |
10218 |
0.11 |
chr9_66158579_66158741 | 5.66 |
Dapk2 |
death-associated protein kinase 2 |
425 |
0.83 |
chr5_136053510_136053661 | 5.63 |
Upk3bl |
uroplakin 3B-like |
907 |
0.4 |
chr2_174477620_174477991 | 5.57 |
Prelid3b |
PRELI domain containing 3B |
4724 |
0.14 |
chr11_94290140_94290302 | 5.57 |
Luc7l3 |
LUC7-like 3 (S. cerevisiae) |
3002 |
0.2 |
chr15_76816855_76818442 | 5.55 |
Arhgap39 |
Rho GTPase activating protein 39 |
322 |
0.82 |
chr16_7099840_7100372 | 5.55 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
30260 |
0.27 |
chr11_84825807_84826461 | 5.54 |
Dhrs11 |
dehydrogenase/reductase (SDR family) member 11 |
2830 |
0.16 |
chr3_135843797_135843956 | 5.53 |
4933401H06Rik |
RIKEN cDNA 4933401H06 gene |
3607 |
0.18 |
chr5_144317459_144317816 | 5.53 |
Baiap2l1 |
BAI1-associated protein 2-like 1 |
28730 |
0.12 |
chr9_35105556_35106095 | 5.52 |
St3gal4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
842 |
0.54 |
chr5_119670248_119671090 | 5.49 |
Tbx3 |
T-box 3 |
0 |
0.93 |
chr2_167563411_167563937 | 5.49 |
Gm11476 |
predicted gene 11476 |
10360 |
0.12 |
chrX_53052410_53053563 | 5.48 |
Gm28730 |
predicted gene 28730 |
173 |
0.64 |
chr10_117106670_117106977 | 5.48 |
Frs2 |
fibroblast growth factor receptor substrate 2 |
24023 |
0.12 |
chr11_117792296_117792500 | 5.47 |
Gm11724 |
predicted gene 11724 |
1085 |
0.24 |
chr5_113986364_113986545 | 5.46 |
Ssh1 |
slingshot protein phosphatase 1 |
3289 |
0.17 |
chr13_99355683_99355861 | 5.44 |
Mrps27 |
mitochondrial ribosomal protein S27 |
10228 |
0.19 |
chr15_25663141_25663443 | 5.43 |
Myo10 |
myosin X |
11218 |
0.18 |
chr6_120463373_120463791 | 5.38 |
Il17ra |
interleukin 17 receptor A |
335 |
0.85 |
chr4_149307680_149308484 | 5.35 |
Kif1b |
kinesin family member 1B |
389 |
0.8 |
chr13_46918635_46918792 | 5.34 |
Kif13a |
kinesin family member 13A |
11004 |
0.13 |
chr3_127929993_127930179 | 5.32 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
13914 |
0.14 |
chr6_72109561_72109904 | 5.32 |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
5500 |
0.13 |
chr4_135898801_135898969 | 5.32 |
Cnr2 |
cannabinoid receptor 2 (macrophage) |
3491 |
0.13 |
chr3_103020186_103021519 | 5.31 |
Csde1 |
cold shock domain containing E1, RNA binding |
188 |
0.92 |
chr2_146099017_146099372 | 5.30 |
Cfap61 |
cilia and flagella associated protein 61 |
51943 |
0.15 |
chr11_62826279_62826430 | 5.29 |
Trim16 |
tripartite motif-containing 16 |
5885 |
0.13 |
chr19_4859073_4859231 | 5.29 |
Ctsf |
cathepsin F |
141 |
0.89 |
chr4_141573436_141573606 | 5.28 |
Fblim1 |
filamin binding LIM protein 1 |
22948 |
0.1 |
chr2_60872443_60872600 | 5.26 |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
8917 |
0.28 |
chr10_62339575_62340379 | 5.25 |
Hk1os |
hexokinase 1, opposite strand |
279 |
0.71 |
chr4_137476743_137476962 | 5.25 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
8049 |
0.14 |
chr11_109557350_109557676 | 5.25 |
Arsg |
arylsulfatase G |
13759 |
0.16 |
chr1_154034449_154034624 | 5.22 |
Gm28286 |
predicted gene 28286 |
235 |
0.92 |
chr4_135623188_135623705 | 5.22 |
1700029M20Rik |
RIKEN cDNA 1700029M20 gene |
3209 |
0.2 |
chr5_115436438_115437458 | 5.21 |
4930430O22Rik |
RIKEN cDNA 4930430O22 gene |
304 |
0.74 |
chr11_115805038_115805337 | 5.18 |
Caskin2 |
CASK-interacting protein 2 |
2915 |
0.13 |
chr2_174478008_174478209 | 5.14 |
Prelid3b |
PRELI domain containing 3B |
5027 |
0.13 |
chr15_102302559_102302908 | 5.14 |
Gm49480 |
predicted gene, 49480 |
6029 |
0.08 |
chr15_82794220_82794587 | 5.11 |
Cyp2d26 |
cytochrome P450, family 2, subfamily d, polypeptide 26 |
109 |
0.93 |
chr2_73047556_73047880 | 5.11 |
Sp3os |
trans-acting transcription factor 3, opposite strand |
60477 |
0.08 |
chr12_79044710_79045063 | 5.11 |
Plekhh1 |
pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 |
9250 |
0.15 |
chr17_48272064_48272554 | 5.10 |
Treml4 |
triggering receptor expressed on myeloid cells-like 4 |
130 |
0.94 |
chr3_103914017_103915242 | 5.08 |
Rsbn1 |
rosbin, round spermatid basic protein 1 |
62 |
0.95 |
chr9_101327066_101327217 | 5.05 |
Gm28660 |
predicted gene 28660 |
10831 |
0.16 |
chr13_9107657_9107865 | 5.05 |
Larp4b |
La ribonucleoprotein domain family, member 4B |
13779 |
0.15 |
chr13_92609867_92610073 | 5.04 |
Serinc5 |
serine incorporator 5 |
1121 |
0.54 |
chr14_14351950_14353283 | 5.03 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr3_97062885_97063210 | 5.02 |
4930573H18Rik |
RIKEN cDNA 4930573H18 gene |
29738 |
0.12 |
chr15_80157312_80157463 | 5.00 |
Mgat3 |
mannoside acetylglucosaminyltransferase 3 |
16334 |
0.11 |
chr2_157100325_157100533 | 4.98 |
Samhd1 |
SAM domain and HD domain, 1 |
9611 |
0.14 |
chr2_27982514_27982684 | 4.97 |
Col5a1 |
collagen, type V, alpha 1 |
34842 |
0.16 |
chr4_115088603_115088783 | 4.94 |
Pdzk1ip1 |
PDZK1 interacting protein 1 |
15 |
0.97 |
chr14_69485840_69486025 | 4.94 |
Gm37094 |
predicted gene, 37094 |
14458 |
0.1 |
chr13_96698181_96698347 | 4.93 |
Gm48575 |
predicted gene, 48575 |
20141 |
0.14 |
chr8_111393298_111394128 | 4.93 |
Fa2h |
fatty acid 2-hydroxylase |
105 |
0.96 |
chr4_136180474_136181190 | 4.91 |
E2f2 |
E2F transcription factor 2 |
49 |
0.97 |
chr10_111670643_111671060 | 4.90 |
Gm47864 |
predicted gene, 47864 |
21039 |
0.16 |
chr7_140955310_140955824 | 4.90 |
Gm45717 |
predicted gene 45717 |
370 |
0.44 |
chr11_115842218_115842650 | 4.89 |
Llgl2 |
LLGL2 scribble cell polarity complex component |
8111 |
0.1 |
chr9_108379420_108379571 | 4.89 |
Usp4 |
ubiquitin specific peptidase 4 (proto-oncogene) |
1876 |
0.15 |
chr10_63272949_63273252 | 4.87 |
Gm47615 |
predicted gene, 47615 |
3010 |
0.16 |
chr17_86753909_86754216 | 4.86 |
Epas1 |
endothelial PAS domain protein 1 |
362 |
0.87 |
chr18_62165959_62166113 | 4.86 |
Adrb2 |
adrenergic receptor, beta 2 |
13923 |
0.18 |
chr12_71936600_71936835 | 4.85 |
Daam1 |
dishevelled associated activator of morphogenesis 1 |
46987 |
0.14 |
chr5_100643889_100644395 | 4.85 |
Coq2 |
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
20277 |
0.13 |
chr17_39845953_39846216 | 4.84 |
CT010467.1 |
18s RNA, related sequence 5 |
269 |
0.9 |
chr10_61920292_61920886 | 4.84 |
Gm5750 |
predicted gene 5750 |
39035 |
0.14 |
chr7_127768560_127769629 | 4.83 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
721 |
0.4 |
chr7_28925406_28925715 | 4.83 |
Actn4 |
actinin alpha 4 |
6339 |
0.11 |
chr18_56977792_56978080 | 4.82 |
C330018D20Rik |
RIKEN cDNA C330018D20 gene |
2568 |
0.32 |
chr2_26342024_26342508 | 4.80 |
Gpsm1 |
G-protein signalling modulator 1 (AGS3-like, C. elegans) |
23 |
0.95 |
chr2_167987787_167988000 | 4.79 |
Ripor3 |
RIPOR family member 3 |
1138 |
0.45 |
chr19_47562344_47562495 | 4.79 |
Slk |
STE20-like kinase |
17259 |
0.13 |
chr8_119669825_119669996 | 4.77 |
Gm32352 |
predicted gene, 32352 |
971 |
0.41 |
chr9_62341481_62341954 | 4.76 |
Anp32a |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A |
185 |
0.95 |
chr11_86577252_86577628 | 4.76 |
Mir21a |
microRNA 21a |
6718 |
0.15 |
chr13_51644632_51645362 | 4.75 |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
235 |
0.91 |
chr9_111119010_111119184 | 4.74 |
Lrrfip2 |
leucine rich repeat (in FLII) interacting protein 2 |
332 |
0.86 |
chr11_82038634_82038785 | 4.74 |
Gm17268 |
predicted gene, 17268 |
147 |
0.93 |
chr10_128368237_128369297 | 4.73 |
Coq10a |
coenzyme Q10A |
76 |
0.91 |
chr5_24426050_24426729 | 4.72 |
Slc4a2 |
solute carrier family 4 (anion exchanger), member 2 |
442 |
0.6 |
chr19_47432341_47432749 | 4.72 |
Sh3pxd2a |
SH3 and PX domains 2A |
22186 |
0.18 |
chr14_57089155_57089477 | 4.71 |
Gjb2 |
gap junction protein, beta 2 |
15386 |
0.14 |
chr8_123982265_123983435 | 4.69 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
272 |
0.84 |
chr17_28832918_28833228 | 4.67 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
4991 |
0.11 |
chr19_46396648_46397747 | 4.65 |
Sufu |
SUFU negative regulator of hedgehog signaling |
171 |
0.89 |
chr19_5827870_5828029 | 4.63 |
Neat1 |
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
63 |
0.93 |
chr15_77911096_77911448 | 4.62 |
Txn2 |
thioredoxin 2 |
4428 |
0.18 |
chr12_80813962_80814126 | 4.62 |
Susd6 |
sushi domain containing 6 |
23485 |
0.12 |
chr19_42788354_42788676 | 4.61 |
Hps1 |
HPS1, biogenesis of lysosomal organelles complex 3 subunit 1 |
8537 |
0.17 |
chr14_63231380_63231561 | 4.61 |
Gata4 |
GATA binding protein 4 |
13778 |
0.16 |
chr5_139805983_139806169 | 4.60 |
Tmem184a |
transmembrane protein 184a |
1904 |
0.22 |
chr6_120235996_120236153 | 4.59 |
B4galnt3 |
beta-1,4-N-acetyl-galactosaminyl transferase 3 |
6569 |
0.22 |
chr9_122069618_122069769 | 4.58 |
Gm39465 |
predicted gene, 39465 |
18230 |
0.11 |
chr7_45677754_45677905 | 4.58 |
Ntn5 |
netrin 5 |
6193 |
0.06 |
chr12_99530050_99530394 | 4.58 |
Foxn3 |
forkhead box N3 |
33286 |
0.12 |
chr5_148361109_148361516 | 4.57 |
Slc7a1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
10234 |
0.23 |
chr11_105151524_105151736 | 4.57 |
Mettl2 |
methyltransferase like 2 |
14067 |
0.13 |
chr6_88758260_88758436 | 4.57 |
Gm43999 |
predicted gene, 43999 |
15621 |
0.11 |
chr11_103096734_103097241 | 4.57 |
Plcd3 |
phospholipase C, delta 3 |
4604 |
0.13 |
chr4_138272669_138272956 | 4.57 |
Kif17 |
kinesin family member 17 |
10313 |
0.11 |
chr17_34099031_34099203 | 4.56 |
Gm50333 |
predicted gene, 50333 |
812 |
0.28 |
chr17_86335093_86335290 | 4.56 |
2010106C02Rik |
RIKEN cDNA 2010106C02 gene |
48013 |
0.17 |
chr16_14162766_14163831 | 4.55 |
Nde1 |
nudE neurodevelopment protein 1 |
0 |
0.52 |
chr4_57560163_57560332 | 4.55 |
Pakap |
paralemmin A kinase anchor protein |
7912 |
0.27 |
chr7_81057985_81058291 | 4.55 |
Alpk3 |
alpha-kinase 3 |
538 |
0.57 |
chr5_75460291_75460442 | 4.54 |
Gm42800 |
predicted gene 42800 |
60994 |
0.11 |
chr14_65101067_65101230 | 4.54 |
Extl3 |
exostosin-like glycosyltransferase 3 |
3042 |
0.27 |
chrX_93831605_93832731 | 4.53 |
Pdk3 |
pyruvate dehydrogenase kinase, isoenzyme 3 |
33 |
0.98 |
chr4_139337211_139337402 | 4.53 |
AL807811.1 |
aldo-keto reductase family 7 member A2 (AKR7A2) pseudogene |
126 |
0.84 |
chr8_94901065_94901679 | 4.52 |
Ccdc102a |
coiled-coil domain containing 102A |
16149 |
0.1 |
chr19_53258446_53258597 | 4.51 |
1700001K23Rik |
RIKEN cDNA 1700001K23 gene |
3301 |
0.2 |
chr9_50856310_50857724 | 4.49 |
Ppp2r1b |
protein phosphatase 2, regulatory subunit A, beta |
38 |
0.97 |
chr15_38566968_38567174 | 4.48 |
Gm29697 |
predicted gene, 29697 |
6925 |
0.13 |
chr3_104142478_104142673 | 4.45 |
Gm42702 |
predicted gene 42702 |
2574 |
0.12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 3.2 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
2.4 | 7.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
2.3 | 6.9 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
2.3 | 9.1 | GO:0003166 | bundle of His development(GO:0003166) |
2.1 | 6.2 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
2.0 | 6.1 | GO:0032439 | endosome localization(GO:0032439) |
2.0 | 8.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
2.0 | 5.9 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
2.0 | 7.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.9 | 5.7 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.8 | 9.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.8 | 5.4 | GO:0001555 | oocyte growth(GO:0001555) |
1.8 | 7.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.8 | 3.5 | GO:0002086 | diaphragm contraction(GO:0002086) |
1.8 | 7.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.7 | 13.9 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
1.7 | 5.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.7 | 6.6 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
1.6 | 4.9 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.6 | 3.2 | GO:0070268 | cornification(GO:0070268) |
1.6 | 4.9 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.6 | 3.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.6 | 4.8 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
1.6 | 6.5 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.6 | 4.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.6 | 6.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
1.5 | 6.0 | GO:0043622 | cortical microtubule organization(GO:0043622) |
1.5 | 3.0 | GO:0070672 | response to interleukin-15(GO:0070672) |
1.5 | 4.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.4 | 4.3 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
1.4 | 4.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.4 | 5.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.4 | 5.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.4 | 2.7 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.3 | 1.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.3 | 6.7 | GO:0070836 | caveola assembly(GO:0070836) |
1.3 | 3.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.3 | 3.9 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.3 | 5.1 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
1.3 | 5.1 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
1.3 | 3.8 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
1.3 | 5.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.3 | 3.8 | GO:0051665 | membrane raft localization(GO:0051665) |
1.2 | 5.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.2 | 9.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
1.2 | 2.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.2 | 4.8 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.2 | 3.6 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.2 | 2.4 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
1.2 | 4.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.2 | 2.4 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.2 | 4.7 | GO:0002159 | desmosome assembly(GO:0002159) |
1.2 | 4.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
1.2 | 5.8 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
1.2 | 5.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.1 | 3.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.1 | 4.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.1 | 4.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.1 | 4.4 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.1 | 3.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.1 | 2.2 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.1 | 5.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.1 | 3.2 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.1 | 4.3 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
1.1 | 3.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.0 | 8.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.0 | 2.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.0 | 3.1 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
1.0 | 2.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.0 | 11.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
1.0 | 2.0 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
1.0 | 3.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.0 | 3.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.0 | 2.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
1.0 | 3.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.0 | 5.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.0 | 2.0 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.0 | 4.9 | GO:0072553 | terminal button organization(GO:0072553) |
1.0 | 1.0 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.0 | 5.8 | GO:0042045 | epithelial fluid transport(GO:0042045) |
1.0 | 3.9 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.0 | 2.9 | GO:0036166 | phenotypic switching(GO:0036166) |
0.9 | 9.3 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.9 | 4.5 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.9 | 1.8 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.9 | 2.7 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.9 | 3.5 | GO:0008228 | opsonization(GO:0008228) |
0.9 | 4.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.9 | 1.8 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.9 | 4.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.9 | 3.5 | GO:0032264 | IMP salvage(GO:0032264) |
0.9 | 5.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.9 | 3.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.9 | 3.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.9 | 6.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.9 | 5.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.9 | 3.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.9 | 1.7 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.9 | 5.2 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.9 | 4.3 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.9 | 1.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.8 | 3.4 | GO:0015825 | L-serine transport(GO:0015825) |
0.8 | 5.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.8 | 3.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.8 | 3.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.8 | 2.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.8 | 2.5 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.8 | 2.4 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.8 | 5.7 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.8 | 8.1 | GO:0018904 | ether metabolic process(GO:0018904) |
0.8 | 3.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.8 | 2.4 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.8 | 8.8 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.8 | 0.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.8 | 5.5 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.8 | 4.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.8 | 14.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.8 | 2.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.8 | 0.8 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.8 | 2.4 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.8 | 0.8 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.8 | 3.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.8 | 2.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.8 | 1.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.8 | 5.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.8 | 1.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.8 | 2.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.8 | 2.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.7 | 3.0 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.7 | 0.7 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.7 | 3.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.7 | 2.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.7 | 2.2 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.7 | 3.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.7 | 4.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.7 | 2.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.7 | 3.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.7 | 2.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.7 | 2.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.7 | 5.1 | GO:0043217 | myelin maintenance(GO:0043217) |
0.7 | 2.9 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.7 | 2.2 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.7 | 2.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.7 | 2.2 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.7 | 2.9 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.7 | 7.9 | GO:0030575 | nuclear body organization(GO:0030575) |
0.7 | 3.6 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.7 | 0.7 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.7 | 4.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.7 | 2.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.7 | 2.8 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.7 | 12.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.7 | 1.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.7 | 1.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.7 | 0.7 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.7 | 5.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.7 | 5.5 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.7 | 2.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.7 | 2.7 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.7 | 6.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.7 | 2.7 | GO:0010288 | response to lead ion(GO:0010288) |
0.7 | 2.7 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.7 | 1.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.7 | 8.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.7 | 1.4 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.7 | 2.0 | GO:0009139 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.7 | 1.3 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.7 | 6.7 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.7 | 3.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.7 | 2.0 | GO:0007418 | ventral midline development(GO:0007418) |
0.7 | 4.6 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.7 | 2.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.7 | 2.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.7 | 11.2 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.7 | 2.0 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.7 | 2.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.7 | 1.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.7 | 3.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.7 | 3.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.7 | 0.7 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.6 | 1.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.6 | 1.9 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.6 | 3.9 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 1.9 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.6 | 1.9 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.6 | 9.6 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.6 | 5.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.6 | 4.4 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.6 | 1.3 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.6 | 0.6 | GO:0061511 | centriole elongation(GO:0061511) |
0.6 | 1.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.6 | 2.5 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.6 | 3.8 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.6 | 1.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.6 | 0.6 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.6 | 2.5 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.6 | 2.5 | GO:0048254 | snoRNA localization(GO:0048254) |
0.6 | 0.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.6 | 8.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.6 | 1.8 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.6 | 1.8 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.6 | 2.4 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.6 | 4.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.6 | 1.2 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.6 | 1.8 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.6 | 1.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.6 | 0.6 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.6 | 12.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.6 | 1.8 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.6 | 3.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.6 | 1.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.6 | 1.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.6 | 2.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.6 | 1.2 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.6 | 2.9 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.6 | 2.9 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.6 | 0.6 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.6 | 2.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.6 | 0.6 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.6 | 6.3 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.6 | 1.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.6 | 2.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.6 | 1.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.6 | 0.6 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.6 | 3.4 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.6 | 3.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.6 | 1.1 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.6 | 2.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.5 | 1.1 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.5 | 1.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.5 | 1.1 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.5 | 1.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.5 | 2.7 | GO:0019695 | choline metabolic process(GO:0019695) |
0.5 | 2.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.5 | 1.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.5 | 0.5 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.5 | 0.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.5 | 2.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 2.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.5 | 1.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.5 | 6.4 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.5 | 1.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.5 | 1.6 | GO:0035973 | aggrephagy(GO:0035973) |
0.5 | 1.6 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.5 | 1.6 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.5 | 4.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 1.6 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 4.8 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.5 | 0.5 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.5 | 0.5 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.5 | 1.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.5 | 8.3 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.5 | 2.6 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.5 | 2.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.5 | 1.5 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.5 | 2.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.5 | 0.5 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.5 | 3.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.5 | 12.3 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.5 | 2.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.5 | 0.5 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.5 | 0.5 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.5 | 2.0 | GO:0045404 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.5 | 0.5 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.5 | 0.5 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.5 | 2.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.5 | 0.5 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.5 | 1.5 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.5 | 1.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.5 | 5.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.5 | 3.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.5 | 3.5 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.5 | 1.5 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.5 | 4.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.5 | 0.5 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.5 | 2.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.5 | 1.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.5 | 1.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.5 | 1.5 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.5 | 4.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.5 | 1.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 1.5 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.5 | 2.4 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.5 | 1.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.5 | 1.9 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.5 | 2.4 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.5 | 1.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.5 | 0.5 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.5 | 1.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.5 | 1.4 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.5 | 0.5 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.5 | 1.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.5 | 2.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.5 | 1.4 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.5 | 0.5 | GO:0007494 | midgut development(GO:0007494) |
0.5 | 3.2 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.5 | 2.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 3.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.5 | 3.7 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.5 | 5.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.5 | 0.9 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.5 | 3.2 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.5 | 4.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.5 | 1.4 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.5 | 1.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.5 | 1.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.5 | 0.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.5 | 1.8 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.5 | 1.4 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.5 | 4.1 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.5 | 1.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.5 | 0.5 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.5 | 2.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.5 | 0.5 | GO:0009750 | response to fructose(GO:0009750) |
0.4 | 1.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.4 | 3.1 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.4 | 0.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 1.3 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.4 | 0.9 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 0.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.4 | 3.5 | GO:0032782 | bile acid secretion(GO:0032782) |
0.4 | 0.4 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.4 | 0.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.4 | 2.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.4 | 2.6 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.4 | 0.4 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.4 | 1.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.4 | 1.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 1.3 | GO:0000019 | regulation of mitotic recombination(GO:0000019) negative regulation of mitotic recombination(GO:0045950) |
0.4 | 3.0 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.4 | 0.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.4 | 1.7 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.4 | 1.7 | GO:0018101 | protein citrullination(GO:0018101) |
0.4 | 1.3 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.4 | 1.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.4 | 1.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 0.4 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.4 | 1.3 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.4 | 3.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.4 | 2.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 7.3 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.4 | 0.9 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.4 | 0.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 3.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.4 | 2.5 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.4 | 1.3 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process through glucose-1-phosphate(GO:0061622) glycolytic process from galactose(GO:0061623) |
0.4 | 4.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.4 | 0.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.4 | 1.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 0.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.4 | 1.3 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.4 | 0.4 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.4 | 1.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 0.4 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.4 | 2.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.4 | 0.8 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.4 | 1.3 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.4 | 0.4 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.4 | 1.3 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.4 | 7.1 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.4 | 1.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.4 | 0.8 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.4 | 0.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.4 | 0.8 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.4 | 0.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 1.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.4 | 0.4 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.4 | 5.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.4 | 0.8 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.4 | 2.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.4 | 3.6 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.4 | 0.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.4 | 2.0 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.4 | 1.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.4 | 2.4 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.4 | 1.6 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.4 | 4.8 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.4 | 0.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.4 | 1.6 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.4 | 0.8 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.4 | 1.2 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.4 | 1.2 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.4 | 0.8 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.4 | 2.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 4.0 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.4 | 3.2 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.4 | 3.6 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.4 | 0.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.4 | 0.4 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.4 | 0.4 | GO:0050904 | diapedesis(GO:0050904) |
0.4 | 2.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.4 | 2.7 | GO:0007097 | nuclear migration(GO:0007097) |
0.4 | 0.8 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.4 | 1.6 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 0.8 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.4 | 1.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.4 | 1.9 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.4 | 3.5 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.4 | 3.9 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.4 | 2.7 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.4 | 1.2 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.4 | 3.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.4 | 3.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.4 | 5.8 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.4 | 1.2 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.4 | 0.8 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.4 | 1.5 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.4 | 3.8 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.4 | 1.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 1.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 6.9 | GO:0045214 | sarcomere organization(GO:0045214) |
0.4 | 1.5 | GO:0009838 | abscission(GO:0009838) |
0.4 | 0.8 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.4 | 0.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 0.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 3.0 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.4 | 2.6 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.4 | 2.6 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.4 | 1.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 0.7 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.4 | 0.4 | GO:0036257 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
0.4 | 2.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.4 | 1.5 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.4 | 3.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.4 | 1.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.4 | 1.1 | GO:0000087 | mitotic M phase(GO:0000087) |
0.4 | 1.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 2.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.4 | 0.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.4 | 1.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.4 | 2.2 | GO:1903624 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.4 | 1.5 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.4 | 0.7 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.4 | 0.4 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.4 | 1.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 1.8 | GO:0042737 | drug catabolic process(GO:0042737) |
0.4 | 0.7 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.4 | 1.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.4 | 0.7 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.4 | 2.5 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.4 | 1.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.4 | 1.1 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.4 | 0.4 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.4 | 1.1 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.4 | 1.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.4 | 2.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.4 | 1.4 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.4 | 1.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.4 | 0.7 | GO:0033483 | gas homeostasis(GO:0033483) |
0.4 | 2.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 2.5 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.4 | 0.7 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.4 | 1.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.4 | 0.7 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.4 | 0.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 1.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 5.6 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.3 | 1.0 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 0.3 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.3 | 4.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 1.0 | GO:1901524 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.3 | 1.4 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.3 | 2.4 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.3 | 0.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 1.0 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.3 | 2.8 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.3 | 0.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.3 | 1.7 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 2.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 0.3 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.3 | 1.4 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.3 | 1.0 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 0.3 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.3 | 0.7 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.3 | 0.3 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.3 | 1.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.3 | 2.0 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.3 | 1.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 0.7 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.3 | 1.7 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.3 | 1.7 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.3 | 1.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.3 | 4.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 1.7 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.3 | 2.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.3 | 0.3 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.3 | 0.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 2.3 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.3 | 1.3 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.3 | 0.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.3 | 1.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 2.0 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.3 | 1.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.3 | 2.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 0.7 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
0.3 | 0.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.3 | 1.6 | GO:1904970 | brush border assembly(GO:1904970) |
0.3 | 1.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.3 | 3.3 | GO:0006903 | vesicle targeting(GO:0006903) |
0.3 | 0.3 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.3 | 1.0 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.3 | 0.3 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.3 | 1.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.3 | 2.3 | GO:0031167 | rRNA methylation(GO:0031167) |
0.3 | 1.3 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.3 | 0.6 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.3 | 0.3 | GO:0097531 | mast cell migration(GO:0097531) |
0.3 | 0.6 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.3 | 1.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 1.3 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.3 | 2.5 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.3 | 0.6 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 2.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.3 | 0.9 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.3 | 1.6 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 0.3 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.3 | 0.6 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.3 | 0.3 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.3 | 0.3 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 1.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 0.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 1.5 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.3 | 0.3 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.3 | 0.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.3 | 0.6 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.3 | 0.6 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.3 | 0.3 | GO:0006573 | valine metabolic process(GO:0006573) |
0.3 | 0.6 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.3 | 0.6 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.3 | 0.3 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.3 | 1.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 3.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 1.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 0.9 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 0.6 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.3 | 1.5 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 0.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 0.6 | GO:0048069 | eye pigmentation(GO:0048069) |
0.3 | 1.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 2.1 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.3 | 0.3 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.3 | 1.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.3 | 1.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 0.6 | GO:0071872 | response to epinephrine(GO:0071871) cellular response to epinephrine stimulus(GO:0071872) |
0.3 | 0.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 0.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.3 | 0.9 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.3 | 1.8 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.3 | 0.3 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.3 | 0.6 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 3.3 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.3 | 3.2 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.3 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 0.6 | GO:0045655 | regulation of monocyte differentiation(GO:0045655) |
0.3 | 1.5 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.3 | 0.3 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.3 | 2.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 4.4 | GO:0050779 | RNA destabilization(GO:0050779) |
0.3 | 0.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.3 | 5.0 | GO:0014904 | myotube cell development(GO:0014904) |
0.3 | 1.2 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.3 | 0.9 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.3 | 1.2 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.3 | 0.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 1.1 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) lagging strand elongation(GO:0006273) |
0.3 | 0.3 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.3 | 0.6 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.3 | 0.6 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.3 | 0.9 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.3 | 0.3 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.3 | 0.6 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.3 | 1.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.3 | 1.4 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) positive regulation of sequestering of triglyceride(GO:0010890) |
0.3 | 0.6 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 1.7 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 0.8 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.3 | 2.5 | GO:0014850 | response to muscle activity(GO:0014850) |
0.3 | 0.3 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.3 | 0.6 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.3 | 1.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 0.8 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 2.0 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.3 | 0.6 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.3 | 0.8 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.3 | 0.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.3 | 0.8 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.3 | 0.3 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.3 | 0.3 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.3 | 10.5 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.3 | 0.6 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.3 | 1.6 | GO:0070293 | renal absorption(GO:0070293) |
0.3 | 3.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.3 | 1.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.3 | 2.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.3 | 1.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.3 | 0.3 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.3 | 0.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.3 | 0.8 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.3 | 0.8 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.8 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.3 | 1.4 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.3 | 0.8 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.3 | 0.3 | GO:0042117 | monocyte activation(GO:0042117) |
0.3 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 1.9 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.3 | 1.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.3 | 0.3 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.3 | 0.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.3 | 0.3 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.3 | 0.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.3 | 0.3 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.3 | 1.0 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 2.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.3 | 1.3 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.3 | 2.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.3 | 0.8 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.3 | 0.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 0.3 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.3 | 0.8 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.3 | 0.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.3 | 4.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 0.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 1.8 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.3 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.3 | 0.5 | GO:1901163 | regulation of trophoblast cell migration(GO:1901163) |
0.3 | 1.0 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.3 | 1.3 | GO:0006547 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.3 | 3.5 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.3 | 0.8 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 1.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.3 | 0.5 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.3 | 0.5 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.7 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 1.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 0.5 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.2 | 2.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 2.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 2.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.2 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.2 | 0.2 | GO:1904996 | positive regulation of leukocyte tethering or rolling(GO:1903238) positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.2 | 2.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 1.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 2.5 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.2 | 1.0 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 0.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.7 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.2 | 0.2 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.2 | 0.2 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.2 | 1.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.2 | 2.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.7 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.2 | 2.4 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.2 | 1.5 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.2 | 1.2 | GO:0034332 | adherens junction organization(GO:0034332) |
0.2 | 0.7 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.2 | GO:1902403 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.2 | 0.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 0.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 0.2 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.2 | 1.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.7 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.2 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.2 | 0.5 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.9 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.2 | 4.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 0.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 3.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.2 | 0.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.2 | 2.1 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.2 | 0.7 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 0.9 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.5 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 0.5 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 0.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 3.5 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 0.2 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.2 | 0.7 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.7 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.2 | 4.6 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.2 | 0.2 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.2 | 0.7 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.2 | 2.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 2.0 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.5 | GO:0032898 | neurotrophin production(GO:0032898) |
0.2 | 0.4 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
0.2 | 1.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 0.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.2 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.2 | 1.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 0.7 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.2 | 0.9 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 1.3 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.2 | 0.9 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.2 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 0.9 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.2 | 0.2 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.2 | 2.6 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.2 | 0.4 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 1.5 | GO:0007398 | ectoderm development(GO:0007398) |
0.2 | 2.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.2 | 0.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 0.4 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 0.7 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 0.7 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.2 | 0.2 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.2 | 0.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 0.4 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.2 | 1.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 1.9 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.2 | 0.2 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.2 | 1.3 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 1.9 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 0.4 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.2 | 3.2 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.2 | 1.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.2 | 0.6 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.2 | 1.5 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 | 1.5 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.2 | 1.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.9 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 1.1 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.2 | 0.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 0.4 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.6 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.2 | 0.8 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 1.1 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 0.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 1.1 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.2 | 10.7 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 0.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.6 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.8 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.2 | 0.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 1.8 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.2 | 0.8 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.2 | 0.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 0.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.6 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.2 | 0.6 | GO:0031946 | negative regulation of glucocorticoid metabolic process(GO:0031944) regulation of glucocorticoid biosynthetic process(GO:0031946) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.2 | 0.6 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.2 | 0.6 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.2 | 0.4 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 17.0 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.2 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 0.6 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.4 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.2 | 0.2 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.2 | 0.8 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.2 | 0.8 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.2 | 0.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 5.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 1.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 2.4 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 0.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.4 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.2 | 0.2 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.2 | 0.4 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.2 | 0.8 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 1.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 1.6 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 1.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 4.1 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.2 | 1.8 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 2.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 0.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.2 | 0.4 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.2 | 0.6 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.2 | 0.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 0.4 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.2 | 0.4 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.2 | 1.0 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.2 | 0.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 0.4 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 0.2 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.2 | 0.4 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.2 | 1.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.4 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 1.3 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.2 | 0.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.2 | 2.9 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.2 | 0.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 2.3 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 1.5 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 0.9 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 1.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 0.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 0.6 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.2 | 0.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.4 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 0.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 0.2 | GO:0045073 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 0.6 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 0.4 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
0.2 | 2.0 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.2 | 2.0 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.2 | 0.6 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 0.4 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
0.2 | 1.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 0.7 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.5 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.2 | 0.5 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.2 | 1.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 1.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 0.4 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.2 | 0.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.9 | GO:0006560 | proline metabolic process(GO:0006560) |
0.2 | 0.2 | GO:0032342 | aldosterone biosynthetic process(GO:0032342) |
0.2 | 0.7 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.2 | 1.4 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 0.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.2 | 0.2 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.2 | 1.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 0.5 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.2 | 0.5 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 0.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 0.7 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 0.4 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.2 | 2.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 0.7 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.2 | 5.1 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.2 | 0.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 0.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 0.7 | GO:0070266 | necroptotic process(GO:0070266) |
0.2 | 0.3 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.2 | 1.9 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 1.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.5 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.2 | 2.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 10.5 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 0.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.2 | GO:0036314 | response to sterol(GO:0036314) |
0.2 | 0.5 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.2 | 3.0 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 0.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 0.5 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.2 | 0.5 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 1.8 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 0.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.8 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.2 | 0.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 0.7 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.2 | 0.5 | GO:0070627 | ferrous iron import(GO:0070627) |
0.2 | 0.7 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.2 | 0.5 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.2 | 0.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.2 | 0.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 0.2 | GO:0048818 | regulation of glucocorticoid metabolic process(GO:0031943) positive regulation of hair follicle maturation(GO:0048818) |
0.2 | 0.7 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.2 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 0.8 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 4.3 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 1.5 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 0.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 1.0 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.2 | 5.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 1.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 0.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.8 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.2 | 0.5 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.2 | 0.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.5 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.2 | 0.3 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.2 | 0.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.2 | 0.2 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.2 | 0.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 1.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 0.3 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.2 | 0.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.2 | 4.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 1.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.2 | 0.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 0.2 | GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043370) |
0.2 | 0.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 1.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.6 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.2 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 0.3 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) |
0.2 | 2.4 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.2 | 0.5 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.3 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.2 | 0.5 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 0.2 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.2 | 0.2 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 0.2 | GO:0010934 | macrophage cytokine production(GO:0010934) |
0.2 | 0.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 2.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.3 | GO:0032375 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.2 | 0.3 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 | 0.3 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 0.2 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.2 | 0.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 0.3 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.2 | 0.5 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.2 | 2.6 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 1.1 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.2 | 3.8 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.2 | 0.9 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 0.6 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.2 | 0.3 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.2 | 0.3 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.2 | 0.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.1 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.1 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 4.0 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 1.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 1.0 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.1 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.1 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.1 | 0.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.9 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 0.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.1 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 0.4 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 4.4 | GO:0001889 | liver development(GO:0001889) |
0.1 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.4 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 1.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 1.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.1 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.1 | 0.1 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.1 | 0.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 1.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 1.0 | GO:0030878 | thyroid gland development(GO:0030878) |
0.1 | 0.1 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.1 | 1.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 1.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 2.0 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.1 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 1.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.8 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) rhombomere 4 development(GO:0021570) |
0.1 | 0.7 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.3 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.1 | 0.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.7 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 2.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 3.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.3 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.3 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.1 | 1.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.9 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.3 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.4 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.5 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.9 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 1.7 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.1 | 0.1 | GO:0044766 | multi-organism transport(GO:0044766) multi-organism localization(GO:1902579) |
0.1 | 0.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.1 | GO:0032616 | interleukin-13 production(GO:0032616) |
0.1 | 0.4 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.1 | 0.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.3 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.5 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.5 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
0.1 | 0.4 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.6 | GO:0018200 | protein polyglutamylation(GO:0018095) peptidyl-glutamic acid modification(GO:0018200) |
0.1 | 0.2 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 1.9 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.1 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.4 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 0.2 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.1 | 0.4 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 1.0 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.7 | GO:0001893 | maternal placenta development(GO:0001893) |
0.1 | 0.2 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.5 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 2.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.5 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.2 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.7 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.5 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.7 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 0.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.1 | 0.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 0.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.1 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.1 | 0.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.1 | 0.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.1 | 0.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.4 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.2 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 1.2 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.1 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.2 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.1 | 0.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.1 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) |
0.1 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 1.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 1.5 | GO:0033047 | regulation of mitotic sister chromatid segregation(GO:0033047) |
0.1 | 0.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 1.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.6 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.3 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.1 | 0.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.4 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
0.1 | 0.2 | GO:1903423 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.1 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.1 | 0.1 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) |
0.1 | 0.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.5 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.2 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.1 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.1 | 0.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.3 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.1 | 0.5 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.1 | 0.4 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.1 | 3.8 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.5 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.1 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.1 | 1.4 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.9 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.3 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 0.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 1.5 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 1.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.4 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 3.5 | GO:0016573 | histone acetylation(GO:0016573) |
0.1 | 1.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.1 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.4 | GO:0031506 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 0.8 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 0.1 | GO:0051306 | mitotic sister chromatid separation(GO:0051306) |
0.1 | 0.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.1 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.3 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.1 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.1 | 0.3 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 1.6 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 3.8 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 2.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.2 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.1 | 0.6 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.2 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.3 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.1 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.1 | 0.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 1.7 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.4 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.2 | GO:2000544 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.1 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.4 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.1 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.2 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.1 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.2 | GO:1902893 | regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902893) |
0.1 | 0.2 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.1 | 4.3 | GO:0043409 | negative regulation of MAPK cascade(GO:0043409) |
0.1 | 0.2 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.6 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.2 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 3.3 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.1 | GO:2000136 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) regulation of cell proliferation involved in heart morphogenesis(GO:2000136) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.1 | 0.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.5 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.6 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.1 | 0.5 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.2 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.2 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.1 | GO:0072678 | T cell migration(GO:0072678) |
0.1 | 0.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.1 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.1 | 0.3 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.1 | 0.1 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.1 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.3 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.2 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.1 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.3 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 1.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.4 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.1 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.1 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.1 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.6 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.1 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 1.1 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.1 | GO:0060026 | convergent extension(GO:0060026) convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.3 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.1 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.1 | 0.1 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.1 | 0.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.1 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 0.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.1 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.1 | 0.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.6 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 1.1 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.1 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.1 | 2.0 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 1.8 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.4 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.7 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.3 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.1 | 0.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.3 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.1 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.1 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
0.1 | 0.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.3 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.1 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.1 | 0.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 0.2 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.1 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 1.3 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.1 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.1 | 0.3 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 2.1 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.3 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 0.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.5 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.4 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.1 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 4.3 | GO:0071216 | cellular response to biotic stimulus(GO:0071216) |
0.1 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.4 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.1 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.5 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.1 | GO:2000142 | regulation of DNA-templated transcription, initiation(GO:2000142) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.1 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.1 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.4 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.1 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.1 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.0 | GO:0032849 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.0 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 1.2 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 0.4 | GO:0019915 | lipid storage(GO:0019915) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.4 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.0 | 0.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 0.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.1 | GO:0006690 | icosanoid metabolic process(GO:0006690) fatty acid derivative metabolic process(GO:1901568) |
0.0 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.2 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.5 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 0.0 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.0 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.7 | GO:0042755 | eating behavior(GO:0042755) |
0.0 | 0.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.1 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.0 | 0.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.0 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.0 | 0.1 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.0 | 0.2 | GO:0034397 | telomere localization(GO:0034397) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.1 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.2 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.0 | 0.0 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.0 | 0.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.0 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.0 | 0.0 | GO:0016553 | base conversion or substitution editing(GO:0016553) cytidine to uridine editing(GO:0016554) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.3 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.1 | GO:0046851 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.0 | 0.5 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.1 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.0 | 0.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.1 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 0.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.1 | GO:1902116 | negative regulation of cilium assembly(GO:1902018) negative regulation of organelle assembly(GO:1902116) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:0002248 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.0 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.5 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) |
0.0 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.4 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.0 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.0 | 0.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.3 | GO:0007584 | response to nutrient(GO:0007584) |
0.0 | 0.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.2 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.0 | 2.2 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:0032673 | regulation of interleukin-4 production(GO:0032673) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.1 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.0 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.0 | 0.0 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.0 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.1 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.0 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.3 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.1 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.3 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.0 | 0.1 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.0 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.0 | 1.1 | GO:0043627 | response to estrogen(GO:0043627) |
0.0 | 0.0 | GO:0002586 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.0 | 0.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.1 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.0 | 0.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) regulation of testosterone biosynthetic process(GO:2000224) |
0.0 | 0.1 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.0 | 0.0 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.0 | 0.0 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.0 | 0.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.0 | GO:0009415 | response to water(GO:0009415) |
0.0 | 2.5 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.1 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.0 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.0 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.0 | 0.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.0 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.2 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 1.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.3 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.0 | 0.1 | GO:0032677 | regulation of interleukin-8 production(GO:0032677) |
0.0 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.0 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.0 | 0.0 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.0 | GO:0051236 | establishment of RNA localization(GO:0051236) |
0.0 | 0.2 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.0 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.0 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.0 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.0 | 0.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.2 | GO:0019079 | viral genome replication(GO:0019079) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.0 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.0 | 0.0 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.1 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.0 | 0.0 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.0 | 0.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.0 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.8 | GO:0098780 | macromitophagy(GO:0000423) mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.0 | GO:0000279 | M phase(GO:0000279) |
0.0 | 0.0 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.1 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.0 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.0 | 0.0 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.0 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.0 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.0 | 0.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.0 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.0 | 0.0 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.0 | 0.5 | GO:0050817 | coagulation(GO:0050817) |
0.0 | 0.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.0 | 0.1 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.0 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
2.2 | 18.0 | GO:0005861 | troponin complex(GO:0005861) |
2.0 | 6.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.9 | 5.6 | GO:0097513 | myosin II filament(GO:0097513) |
1.6 | 14.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.3 | 6.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.3 | 5.0 | GO:0098536 | deuterosome(GO:0098536) |
1.2 | 8.7 | GO:0042382 | paraspeckles(GO:0042382) |
1.2 | 3.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.1 | 8.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.0 | 3.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.0 | 3.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.0 | 7.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.0 | 14.3 | GO:0031528 | microvillus membrane(GO:0031528) |
1.0 | 3.0 | GO:0031417 | NatC complex(GO:0031417) |
1.0 | 4.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.0 | 3.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.0 | 1.0 | GO:0061574 | ASAP complex(GO:0061574) |
1.0 | 3.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.9 | 7.6 | GO:0045179 | apical cortex(GO:0045179) |
0.9 | 5.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.9 | 2.8 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.9 | 2.8 | GO:0031523 | Myb complex(GO:0031523) |
0.9 | 3.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.9 | 7.7 | GO:0097470 | ribbon synapse(GO:0097470) |
0.8 | 2.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.8 | 2.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.8 | 6.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.8 | 2.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 8.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.7 | 2.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.7 | 2.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 2.8 | GO:0072487 | MSL complex(GO:0072487) |
0.7 | 2.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.7 | 2.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 2.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.7 | 2.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.7 | 1.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.7 | 3.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.6 | 1.9 | GO:0005712 | chiasma(GO:0005712) |
0.6 | 3.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.6 | 8.6 | GO:0000974 | Prp19 complex(GO:0000974) |
0.6 | 0.6 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.6 | 1.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.6 | 2.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.6 | 1.8 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.6 | 1.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.6 | 0.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.6 | 1.7 | GO:0043293 | apoptosome(GO:0043293) |
0.6 | 1.7 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.6 | 2.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.6 | 31.7 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.6 | 1.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.6 | 2.2 | GO:0032021 | NELF complex(GO:0032021) |
0.6 | 7.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.6 | 1.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.6 | 1.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.5 | 2.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.5 | 6.0 | GO:0002102 | podosome(GO:0002102) |
0.5 | 1.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 2.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.5 | 4.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.5 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.5 | 2.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.5 | 1.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.5 | 1.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.5 | 0.5 | GO:0097346 | INO80-type complex(GO:0097346) |
0.5 | 2.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.5 | 4.4 | GO:0042641 | actomyosin(GO:0042641) |
0.5 | 7.2 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 1.0 | GO:0070938 | contractile ring(GO:0070938) |
0.5 | 3.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 1.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.5 | 1.9 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.5 | 0.9 | GO:0097255 | R2TP complex(GO:0097255) |
0.5 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.5 | 3.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 6.7 | GO:0043034 | costamere(GO:0043034) |
0.4 | 10.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.4 | 3.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 2.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.4 | 3.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 3.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 1.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 2.5 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.4 | 12.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 5.6 | GO:0031430 | M band(GO:0031430) |
0.4 | 5.6 | GO:0071010 | prespliceosome(GO:0071010) |
0.4 | 0.4 | GO:0032010 | phagolysosome(GO:0032010) |
0.4 | 1.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 2.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 1.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 0.8 | GO:0000791 | euchromatin(GO:0000791) |
0.4 | 1.5 | GO:0033269 | internode region of axon(GO:0033269) |
0.4 | 2.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.4 | 3.7 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 1.8 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 0.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.4 | 3.3 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.4 | 2.9 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 1.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 10.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 4.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.4 | 5.0 | GO:0031011 | Ino80 complex(GO:0031011) |
0.4 | 3.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 3.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 1.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 0.3 | GO:1990696 | USH2 complex(GO:1990696) |
0.3 | 0.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 7.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 1.0 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.3 | 1.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 1.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 0.3 | GO:0032432 | actin filament bundle(GO:0032432) |
0.3 | 3.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 0.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 1.6 | GO:0043219 | lateral loop(GO:0043219) |
0.3 | 2.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 1.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 3.8 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.3 | 4.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.3 | 0.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 1.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 19.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 0.9 | GO:0035861 | site of double-strand break(GO:0035861) |
0.3 | 0.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 1.2 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 0.9 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 1.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.3 | 2.7 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.3 | 1.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 2.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 1.2 | GO:0000938 | GARP complex(GO:0000938) |
0.3 | 1.2 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.3 | 1.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 0.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 2.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.3 | 3.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 5.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 0.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.3 | 14.4 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 10.7 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 12.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 1.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 3.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 4.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 3.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 15.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.3 | 0.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.3 | 1.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 1.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 0.3 | GO:0042827 | platelet dense granule(GO:0042827) |
0.3 | 0.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 1.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 26.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 1.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 1.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 1.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 0.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.3 | 13.7 | GO:0016605 | PML body(GO:0016605) |
0.3 | 0.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 1.0 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 5.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 1.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 1.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 0.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 8.8 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 4.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 1.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 0.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 3.3 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 0.7 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 2.1 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 0.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 0.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 1.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 1.2 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 0.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 4.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 1.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.7 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 2.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 1.6 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.2 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 2.0 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
0.2 | 10.6 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.2 | 4.2 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 0.2 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.2 | 2.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 0.9 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 1.5 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 7.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 1.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 3.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 0.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 1.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 0.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 1.0 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 1.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 2.7 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 4.1 | GO:1902493 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.2 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 8.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.2 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.2 | 0.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 0.8 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 6.4 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 0.6 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 8.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 2.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 45.7 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 13.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 2.0 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 4.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 3.5 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.2 | 1.5 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.2 | 0.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 2.3 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 0.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 1.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 0.9 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 0.9 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 2.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 5.6 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 9.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 1.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 2.1 | GO:0031672 | A band(GO:0031672) |
0.2 | 0.5 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 0.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.2 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.2 | 1.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 1.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 0.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 0.6 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 0.5 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.2 | 1.6 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 0.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.5 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 43.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 1.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.2 | 0.8 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 1.8 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 1.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 2.7 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 1.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.7 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 1.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 1.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 1.4 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 0.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 1.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.9 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 1.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 9.6 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 1.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 1.0 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 9.7 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.4 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.1 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.1 | 0.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 3.6 | GO:0005844 | polysome(GO:0005844) |
0.1 | 4.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 1.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 1.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 1.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 1.9 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 56.0 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.7 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 7.0 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.6 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 2.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 1.0 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.6 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 1.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.7 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.1 | 0.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 1.8 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 3.4 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 1.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 10.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 1.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 1.4 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.4 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 1.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 1.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 156.8 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 1.0 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.4 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 0.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 2.9 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 78.8 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.2 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.2 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.1 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.2 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 2.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 14.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 3.0 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.1 | 0.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 2.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 1.6 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 3.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 1.3 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.5 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.4 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 1.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 4.1 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 2.0 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.0 | GO:1902911 | protein kinase complex(GO:1902911) |
0.0 | 0.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.0 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 1.4 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.2 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.3 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.0 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.0 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.0 | 0.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 7.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 6.3 | GO:0005739 | mitochondrion(GO:0005739) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 11.0 | GO:0030172 | troponin C binding(GO:0030172) |
2.0 | 14.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.9 | 7.7 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.8 | 5.4 | GO:0031014 | troponin T binding(GO:0031014) |
1.8 | 1.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
1.6 | 4.9 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.6 | 6.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.5 | 7.6 | GO:0070061 | fructose binding(GO:0070061) |
1.5 | 5.9 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.5 | 4.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.4 | 5.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.4 | 4.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.4 | 4.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.4 | 14.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.3 | 5.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.3 | 5.0 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
1.2 | 9.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.2 | 3.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.2 | 3.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.2 | 3.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.1 | 4.6 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.1 | 4.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.1 | 4.5 | GO:0009374 | biotin binding(GO:0009374) |
1.1 | 2.2 | GO:0034618 | arginine binding(GO:0034618) |
1.1 | 4.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.1 | 3.3 | GO:1990188 | euchromatin binding(GO:1990188) |
1.1 | 4.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.1 | 11.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.1 | 12.7 | GO:0044548 | S100 protein binding(GO:0044548) |
1.1 | 4.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.0 | 4.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.0 | 1.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
1.0 | 3.9 | GO:0034549 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
1.0 | 3.9 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.0 | 3.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.9 | 3.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.9 | 2.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.9 | 5.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.9 | 3.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.9 | 2.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.9 | 2.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.9 | 9.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.9 | 2.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.8 | 8.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.8 | 5.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.8 | 3.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.8 | 5.8 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.8 | 2.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.8 | 2.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.8 | 4.9 | GO:0016936 | galactoside binding(GO:0016936) |
0.8 | 4.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.8 | 3.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.8 | 4.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.8 | 4.8 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.8 | 3.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.8 | 7.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.8 | 5.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.8 | 8.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.8 | 3.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.8 | 0.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.8 | 6.0 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.7 | 3.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.7 | 3.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.7 | 2.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.7 | 3.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.7 | 4.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.7 | 2.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.7 | 1.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.7 | 6.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.7 | 0.7 | GO:0043398 | HLH domain binding(GO:0043398) |
0.7 | 3.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.7 | 1.4 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.7 | 2.8 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.7 | 0.7 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.7 | 4.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.7 | 2.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.7 | 10.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.7 | 2.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.7 | 2.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.7 | 8.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.7 | 2.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.7 | 2.0 | GO:0045340 | mercury ion binding(GO:0045340) |
0.7 | 2.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.6 | 3.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.6 | 1.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.6 | 1.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.6 | 3.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.6 | 4.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.6 | 1.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.6 | 3.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.6 | 1.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.6 | 1.9 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.6 | 3.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.6 | 2.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.6 | 1.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.6 | 4.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 2.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.6 | 3.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.6 | 1.8 | GO:0016361 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.6 | 1.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.6 | 3.0 | GO:0070728 | leucine binding(GO:0070728) |
0.6 | 1.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.6 | 1.8 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.6 | 1.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.6 | 2.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.6 | 2.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.6 | 0.6 | GO:0035276 | ethanol binding(GO:0035276) |
0.6 | 5.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.6 | 3.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.6 | 2.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 1.6 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.5 | 3.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.5 | 2.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.5 | 3.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.5 | 3.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 0.5 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.5 | 3.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.5 | 3.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.5 | 11.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.5 | 2.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 1.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.5 | 2.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.5 | 2.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.5 | 3.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.5 | 1.5 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.5 | 2.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 4.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.5 | 1.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 3.1 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.5 | 3.6 | GO:0003896 | DNA primase activity(GO:0003896) |
0.5 | 2.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.5 | 1.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.5 | 1.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.5 | 1.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.5 | 2.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.5 | 1.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.5 | 2.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.5 | 3.0 | GO:0043495 | protein anchor(GO:0043495) |
0.5 | 5.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.5 | 23.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.5 | 2.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.5 | 5.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.5 | 3.9 | GO:0008430 | selenium binding(GO:0008430) |
0.5 | 1.5 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.5 | 1.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.5 | 1.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.5 | 2.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.5 | 1.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.5 | 0.5 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.5 | 1.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 1.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.5 | 3.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.5 | 3.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.4 | 4.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 1.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.4 | 2.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 3.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.4 | 0.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.4 | 2.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 5.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.4 | 1.3 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 0.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.4 | 1.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.4 | 0.9 | GO:0070538 | oleic acid binding(GO:0070538) |
0.4 | 6.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.4 | 1.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.4 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 0.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.4 | 1.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 1.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.4 | 1.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 1.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 4.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 1.7 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 0.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 2.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.4 | 1.3 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.4 | 1.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 3.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 2.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 0.8 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.4 | 1.7 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 1.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.4 | 8.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.4 | 1.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.4 | 2.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.4 | 1.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.4 | 2.0 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 4.5 | GO:0010181 | FMN binding(GO:0010181) |
0.4 | 2.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 3.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 4.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 5.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.4 | 0.8 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.4 | 4.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 0.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 12.5 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.4 | 1.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 1.6 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.4 | 5.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 1.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 1.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 3.1 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 1.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 1.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.4 | 10.8 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.4 | 10.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.4 | 0.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 0.7 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 3.7 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.4 | 2.9 | GO:0018447 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.4 | 4.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 0.7 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
0.4 | 1.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.4 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.4 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 2.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.4 | 1.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.4 | 0.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 1.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 3.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 3.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.3 | 0.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 3.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.3 | 2.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.3 | 1.0 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.3 | 3.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 2.0 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 3.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 1.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 1.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 17.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.3 | 3.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 1.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.3 | 3.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 3.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.3 | 1.0 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 1.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.3 | 3.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 1.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 1.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 1.3 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.3 | 1.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 1.6 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 3.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.3 | 1.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 1.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 0.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 0.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 3.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 7.8 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.3 | 1.9 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.3 | 3.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 0.9 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 4.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 0.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 0.9 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 5.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 1.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 1.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 2.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 1.5 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.3 | 0.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 1.2 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 2.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 1.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 2.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 1.7 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.3 | 2.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 0.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 1.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 0.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 0.6 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 9.5 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.3 | 1.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 1.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 1.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 0.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 3.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 0.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.3 | 1.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 0.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 10.6 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.3 | 0.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 1.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 7.4 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.3 | 1.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 1.6 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.3 | 1.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 4.2 | GO:0016684 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.3 | 2.6 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 2.6 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.3 | 7.0 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.3 | 0.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 0.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 2.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 0.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 0.5 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.3 | 3.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 1.7 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.7 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 12.2 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 1.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 4.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 3.7 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 1.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 1.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 1.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.7 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 1.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 1.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 0.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 1.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 1.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 0.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 1.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 0.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.2 | 4.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 1.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 3.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.2 | 0.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 2.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 1.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 1.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 1.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 5.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 0.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 2.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 2.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 0.7 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 6.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 5.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 2.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.2 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.2 | 0.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.9 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 0.9 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 2.0 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 1.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 0.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 3.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 0.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 0.9 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 3.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 3.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 1.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 1.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.2 | 1.9 | GO:0045182 | translation regulator activity(GO:0045182) |
0.2 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 1.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.2 | 2.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 3.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.6 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 1.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 1.0 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 0.8 | GO:0035671 | enone reductase activity(GO:0035671) |
0.2 | 2.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 1.2 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 1.0 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.2 | 0.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 0.6 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 1.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 1.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 0.6 | GO:0004083 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 0.8 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 1.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 0.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 14.3 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 0.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 0.8 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 1.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 0.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.9 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 3.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 2.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 1.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 2.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 0.2 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.2 | 0.2 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.2 | 0.4 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 0.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 1.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 0.9 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 2.6 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 1.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 1.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 0.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 4.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.2 | 1.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.2 | 0.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 2.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 2.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 0.7 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.2 | 1.0 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 1.7 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.5 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 1.0 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.2 | 5.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 2.0 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 17.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 2.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 0.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 0.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 0.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 0.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 2.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.2 | 0.3 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 0.6 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 1.0 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.2 | 0.5 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.2 | 0.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 3.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.6 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.3 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 2.7 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 0.8 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 0.3 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.2 | 3.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 7.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 1.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 1.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 1.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 0.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.6 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 8.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 6.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.3 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 1.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 1.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.9 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.7 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 3.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 1.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 1.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 2.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 3.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 3.8 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 1.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 1.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.7 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 1.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 3.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 1.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 3.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 15.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 4.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 2.0 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 3.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.1 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 3.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 4.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 2.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 6.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 1.5 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 5.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 5.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.1 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 1.2 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 2.3 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 1.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 1.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 1.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 9.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.5 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 1.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 1.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.2 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.4 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 2.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 1.5 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 5.1 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.7 | GO:0036218 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 0.3 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.6 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 1.4 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.6 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.3 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 1.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.4 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 1.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.4 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 0.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 8.9 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 1.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 1.8 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.1 | 7.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.5 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 1.6 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.3 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 2.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.2 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.1 | 1.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 2.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 7.3 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.2 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) |
0.1 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.2 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 1.4 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 8.8 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.9 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 11.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 1.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 7.3 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.4 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 1.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.1 | GO:0050543 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.1 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.3 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.1 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.1 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 1.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 1.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.1 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.0 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.0 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.4 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.7 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 1.0 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 1.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 3.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 1.0 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 0.0 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 5.9 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 6.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 1.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 1.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 16.4 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 1.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0102344 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.0 | 0.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 2.4 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 0.1 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.3 | GO:0001159 | core promoter proximal region DNA binding(GO:0001159) |
0.0 | 0.5 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.5 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.3 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.0 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.0 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.0 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.0 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.0 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.0 | 0.2 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.3 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 2.0 | GO:0005525 | GTP binding(GO:0005525) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 12.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.9 | 2.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.8 | 1.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.7 | 5.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.7 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.6 | 0.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.6 | 14.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.6 | 10.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.6 | 0.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.6 | 15.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.6 | 18.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.6 | 7.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.5 | 8.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.5 | 7.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.5 | 5.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 8.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.5 | 6.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.5 | 21.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 3.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 12.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.4 | 1.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.4 | 11.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.4 | 1.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 15.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 16.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.4 | 17.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 4.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 3.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 1.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.4 | 10.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.4 | 9.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 5.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 4.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 0.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 2.4 | PID FGF PATHWAY | FGF signaling pathway |
0.3 | 0.3 | ST STAT3 PATHWAY | STAT3 Pathway |
0.3 | 1.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.3 | 4.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 0.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 5.5 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 3.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 0.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 0.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 5.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 4.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 3.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 3.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 5.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 0.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 1.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 13.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 0.9 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.3 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 3.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 5.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 0.8 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 6.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 0.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 1.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 2.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 1.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 1.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 7.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.3 | 4.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 7.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 0.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 6.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 1.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 6.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 2.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 5.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 3.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 4.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 2.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 0.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 6.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 0.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 5.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 8.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 4.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 0.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 13.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 7.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 0.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 0.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 3.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 3.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 2.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 2.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 5.4 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 2.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 0.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 0.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 0.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 0.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 3.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 3.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 30.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 2.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 3.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.4 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 2.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 6.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 2.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 2.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 10.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 10.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.9 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.2 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 25.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.9 | 0.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.9 | 23.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.8 | 9.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.8 | 12.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.7 | 7.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.7 | 8.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.6 | 10.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.6 | 11.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.6 | 6.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.6 | 5.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.6 | 0.6 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.6 | 5.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.6 | 6.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.6 | 7.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.6 | 12.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.6 | 9.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.6 | 8.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.6 | 6.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.6 | 4.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.5 | 6.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.5 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.5 | 8.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.5 | 4.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.5 | 4.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 2.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.5 | 10.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.5 | 4.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 0.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.5 | 0.9 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.4 | 4.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.4 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 1.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 2.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.4 | 2.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 5.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 6.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 4.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.4 | 4.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.4 | 8.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 3.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.4 | 2.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 3.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 3.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 9.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 1.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.4 | 4.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.4 | 1.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.4 | 3.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 4.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 31.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 7.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 5.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 2.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 0.3 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.3 | 7.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 5.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.3 | 3.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 4.6 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.3 | 3.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 4.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 0.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 5.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 1.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 3.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.3 | 2.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 1.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 3.1 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.3 | 1.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 4.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 8.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.3 | 1.2 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 1.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 1.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 5.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 1.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 2.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 4.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 5.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 6.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.3 | 6.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 1.6 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.3 | 5.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 0.3 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.3 | 1.6 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.3 | 5.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 8.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 1.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 4.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 12.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 0.2 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.2 | 2.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 1.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 6.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 4.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 1.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 2.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 0.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 0.5 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.2 | 0.9 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 3.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 3.9 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 1.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 1.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 1.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 1.8 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 4.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 2.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 11.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 3.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 1.6 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.2 | 0.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 2.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 8.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 4.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 7.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 4.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 0.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 2.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 6.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 4.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 10.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 2.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 6.9 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 1.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 0.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 4.0 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.2 | 2.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 9.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 3.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 2.8 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 1.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 2.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 0.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 2.8 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.2 | 0.2 | REACTOME INSULIN RECEPTOR SIGNALLING CASCADE | Genes involved in Insulin receptor signalling cascade |
0.2 | 6.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 6.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 3.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 3.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 1.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 0.3 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 6.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.6 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 1.6 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.1 | 1.7 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 1.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 6.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 1.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 3.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 2.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 2.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 8.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 2.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.5 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 4.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 10.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 2.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 1.7 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 2.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.1 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 8.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 9.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.6 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 1.1 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 1.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 2.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.3 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 1.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.3 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 0.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 1.0 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.1 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.1 | 0.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 0.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 3.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 1.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.5 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.0 | 0.5 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 4.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.7 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 1.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.2 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.2 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.1 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.0 | 0.0 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.0 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |